Study on the clinical significance of Argonaute2 expression in colonic carcinoma by tissue microarray

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 3, 2013, Pages 476-484

  Wang, Ying Xin ^a   Zhang, Xiao Yan ^b   Zhang, Bao Feng ^b   Yang, Chang Qing ^a   Gao, Heng Jun ^a,b  

^a TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

^b Key Laboratory of Health and Disease Genomics   (China)

Author keywords

Argonaute2; Colonic carcinoma; Immunohistochemstry; Tissue mircroarray

Indexed keywords

ARGONAUTE 2 PROTEIN; ARGONAUTE PROTEIN; EIF2C2 PROTEIN, HUMAN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; COLON; COLON CARCINOMA; COLON TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMSTRY; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; TISSUE MICROARRAY; TISSUE MIRCROARRAY; VERY ELDERLY;

ARGONAUTE2; COLONIC CARCINOMA; IMMUNOHISTOCHEMSTRY; TISSUE MIRCROARRAY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ARGONAUTE PROTEINS; COLON; COLONIC NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS;

EID: 84881533480     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Pohl C, Hombach A, Kruis W. Chronic inflam-matory bowel disease and cancer. Hepatogas-troenterology 2000 Jan-Feb; 47: 57-70
2. Grady WM, Carethers JM. Genomic and epi-genetic instability in colorectal cancer patho-genesis. Gastroenterology 2008 Oct; 135: 1079-99
3. Ohta M, Sugimoto T, Seto M, Mohri D, Asaoka Y, Tada M, Tanaka Y, Yamaji Y, Kanai F, Kawabe T, Omata M. Genetic alterations in colorectal cancers with demethylation of insulin-like growth factor II. Hum Pathol 2008 Sep; 39: 1301-8
4. Samowitz WS. Genetic and epigenetic changes in colon cancer. Exp Mol Pathol 2008 Aug; 85: 64-7
5. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006 Nov; 6: 857-66
6. Ambros V. The functions of animal microRNAs Nature 2004 Sep 16; 431: 350-55
7. Bartel DP. MicroRNAs: genomics,biogenesis, mechanism, and function. Cell 2004 Jan 23; 116: 281-97
8. Esquela-Kerscher A, Slack FJ. Oncomirs-mi-croRNAs with a role in cancer. Nat Rev Cancer 2006 Apr; 6: 259-69
9. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcel-lular localization. EMBO J 2002 Sep 2; 21: 4663-70
10. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Rådmark O, Kim S, Kim VN. The nu-clear RNase III Drosha initiates microRNA pro-cessing. Nature 2003 Sep 25; 425: 415-9
11. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003 Dec 15; 17: 3011-6
12. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. Dicer functions in RNA interference and in synthesis of small RNA involved in developental timing in C. ele-gans. Genes Dev 2001 Oct 15; 15: 2654-9
13. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene si-lencing. Cell 2005 Nov 18; 123: 631-40
14. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processsing and gene silencing. Na-ture 2005 Aug 4; 436: 740-4
15. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 2004 Jul 23; 15: 185-97
16. Garmell MA, Xuan Z, Zhang MQ, Hannon GJ. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell mainte-nance, and tumorigenesis. Genes Dev 2002 Nov 1; 16: 2733-42
17. Song JJ, Smith SK, Hannon GJ, Joshua-Tor L. Crystal structure of Argonaute and its implica-tions for RISC slicer activity. Science 2004 Sep 3; 305: 1434-7
18. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshu-Tor L, Hannon GJ. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004 Sep 3; 305: 1437-41
19. Yuan YR, Pei Y, Ma JB, Kuryabyi V, Zhadina M, Meister G, Chen HY, Dauter Z, Tuschl T, Patal DJ. Crystal structure of A. aeolicus Argonaute, a site-specifilc DNA-guided endoribonuclease, provides insights into RISC-mediated Mrna CLEAVAGE. Mol Cell 2005 Aug 5; 19: 405-19
20. Martinez J, Patkaniowska A, Uriaub H, Luhrmann R, Tuschl T. Single-stranded anti-sense siRNAs guide target RNA cleavage in RNAi. Cell 2002 Sep 6; 110: 563-74
21. Deshpande G, Callhon G, Schedl P. Drosophila argonaute-2 is required early in embryogene-sis for the assembly of centric/centromeric heterochromatin, nuclear division, nuclear mi-gration, and germ-cell formation. Genes Dev 2005 Jul 15; 19: 1680-5
22. Tsukioka H, Takahashi M, Mon H, Okano K, Mita K, Shimada T, Lee JM, Kawaguchi Y, Koga K, Kusakabe T. Role of the silkworm argo-naute2 homolog gene in double-strand break repair of extrachromosomal DNA. Nucleci Ac-ids Res 2006 Feb 14; 34: 1092-101
23. Robb GB, Brown KM, Khurana J, Rana TM Spectific and potent RNAi in the nucleus of hu-man cells. Nat Struct Mol Biol 2005 Feb; 12: 133-7
24. Maniataki E, Mourelatos Z. Human mitochon-drial tRNAMet is exported to the cytoplasm and associates with the Argonaute2 protein. RNA 2005 Jun; 11: 849-52
25. Kiriakidou M, Tan GS, Lamprinaki S, De Planell-Saguer M, Nelson PT, Mourelatos Z. An mRNA m7G cap binding-like mitif within human Ago2 represses translation. Cell 2007 Jun 15; 129: 1141-51
26. Rudel S, Flatley A, Weinmann L, Kremmer E, Meister G. A multifunctional human Argo-naute2-specific monocional antibody. RNA 2008 Jun; 14: 1244-53
27. Zhang B, Pan X, Cobb GP, Anderson TA. microR-NAs as oncogenes and tumor suppressors Dev Biol 2007 Feb 1; 302: 1-12
28. Deng S, Calin GA, Croce CM, Coukos G, Zhang L. Mechanlisms of microRNA deregulation in human cancer. Cell Cycle 2008 Sep 1; 7: 2643-6
29. Wu W, Sun M, Zou GM, Chen J. MicroRNA and cancer: current status and prospective. Int J Cancer 2007 Mar 1; 120: 953-60
30. Fillipowicz W, Bhattacharyya SN, Sonenberg N Mechanisms of post-transcriptional regulation by microRNAs:are the answers in sight? Nat Rev Genet 2008 Feb; 9: 102-14
31. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. Human mi-croRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc Natl Acad Sci USA 2004 Mar 2; 101: 2999-3004
32. Muralidhar B, Goldstein LD, Ng G, Winder DM, Palmer RD, Gooding EL, Barbosa-Morais NL, Mukherjee G, Thorne NP, Roberts I, Pett MR, Coleman N. Global microRNA profiles in cervi-cal squamous cell carcinoma depend on Dro-sha expression levels. J Pathol 2007 Aug; 212: 368-77
33. Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW, Dacic S. Overexpression of Dicer in precursor lesions of lung adenocar-cinoma. Cancer Res 2007 Mar 1; 67: 2345-50
34. Chiosea S, Jelezcova E, Chandran U, Acquafon-data M, McHale T, Sobol RW, Dhir R. Up-regula-tion of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol 2006 Nov; 169: 1812-20
35. Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wikenheiser-Brokamp KA, Suarez BK, Whelan AJ, Williams G, Bracamontes D, Messinger Y, Goodfellow PJ. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009 Aug 21; 325: 965
36. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high- throughput molecular profiling of cncer. Hum Mol Genet 2001 Apr; 10: 657-62
37. Mucci NR, Akdas G, Manely S, Rubin MA. Neu-roendocrine expression in metastatic prostate cancer:evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol 2000 Apr; 31: 406-14
38. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP, Sauter G. Tissue microarrays for gene am-plification surveys in many different tumor types. Clin Cancer Res 1999 Aug; 5: 1966-75
39. Richter J, Wagner U, Kononen J, Fijan A, Brud-erer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabi-tarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Kallioniemi OP, Sauter G. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpres-sion in urinary bladder cancer. Am J Pathol 2000 Sep; 157: 787-94
40. Lynch HT, Smyrk TC. Identifying hereditary non-polyposis colorectal cancer. N Engl J Med 1998 May 21; 338: 1537-8
41. Adams BD, Claffey KP, White BA. Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a trans-formed phenotype in breast cancer cells. En-docrinology 2009 Jan; 150: 14-23
42. Yoo NJ, Hur SY, Kim MS, Lee JY, Lee SH. Immu-nohistochemical analysis of RNA-induced si-lencing complex-related proteins AGO2 and TNRC6A in prostate and esophageal cancers APMIS 2010 Apr; 118: 271-6
43. Paukku K, Kalkkinen N, Silvennoinen O, Kon-tula KK, Lehtonen JY. p100 increases AT1R expression through interaction with AT1R 3'-UTR. Nucleic Acids Res 2008 Aug; 36: 4474-87
44. Tsuchiya N, Ochiai M, Nakashima K, Ubagai T, Sugimura T, Nakagama H. SND1, a component of RNA-induced silencing complex, is up-regu-lated in human colon cancers and implicated in early stage colon carcinogenesis. Cancer Res 2007 Oct 1; 67: 9568-76
45. Kuruma H, Kamata Y, Takahashi H, Igarashi K, Kimura T, Miki K, Miki J, Sasaki H, Hayashi N, Egawa S. Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer. Am J Pathol 2009 Jun; 174: 2044-50
46. Lan Li, Chaohui Yu, Hengjun Gao and Youming Li. Argonaute proteins: potential biomarkers for human colon cancer. BMC Cancer 2010 Feb 10; 10: 38